Virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how our bodies detect and respond to viruses and viral replication. The publication explains ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

enabling the novel coronavirus to create more proteins and perhaps carry out more sophisticated replication strategies than other RNA viruses. One of these advantageous proteins is an enzyme ...

Following is a transcript of the video. Narrator: COVID-19 myths have spread just about as quickly as the disease itself, but one myth in particular just won't go away: that SARS-CoV-2 ...

Emerging data as well as knowledge from the SARS and MERS coronavirus outbreaks yield some clues as to why SARS-CoV-2 affects some people worse than others. After a year teaching an algorithm to ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

MOSCOW, January 20. /TASS/. Russian developers have created a number of preparations blocking replication of the coronavirus but so far there are no data on their clinical trials, Russian ...

Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to ...